Outlook Therapeutics, Inc. (NASDAQ:OTLK) has a beta value of 0.31 and has seen 6,160,897 shares traded in the last trading session. The company, currently valued at $138.9 Million, closed the last trade at $1.29 per share which meant it gained $0.14 on the day or 12.17% during that session. The OTLK stock price is -124.03% off its 52-week high price of $2.89 and 61.32% above the 52-week low of $0.499. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.99 Million shares traded. The 3-month trading volume is 1.19 Million shares.
Outlook Therapeutics, Inc. (NASDAQ:OTLK) trade information
Sporting 12.17% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Jun 17 when the OTLK stock price touched $1.39 or saw a rise of 7.19%. Year-to-date, Outlook Therapeutics, Inc. shares have moved 118.64%, while the 5-day performance has seen it change 33.06%. Over the past 30 days, the shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK) have changed 69.29%. Short interest in the company has seen 2.15 Million shares shorted with days to cover at 1.81.
Wall Street analysts have a consensus price target for the stock at $6.05, which means that the shares’ value could jump 368.99% from current levels. The projected low price target is $3.25 while the price target rests at a high of $9. In that case, then, we find that the current price level is +597.67% off the targeted high while a plunge would see the stock lose 151.94% from current levels.
Outlook Therapeutics, Inc. (OTLK) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +22.8% over the past 5 years. Earnings growth for 2020 is a modest +79.7% while over the next 5 years, the company’s earnings are expected to increase by 0%.